X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.biospace.com/article/releases/daiichi-sankyo-announces-late-breaking-phase-1-dose-expansion-data-for-patritumab-deruxtecan-in-patients-with-egfr-mutated-nsclc-at-esmo-2020/?s=73
https://www.fiercebiotech.com/research/pfizer-s-vizimpro-among-three-fda-approved-drugs-combat-covid-lung-cells-report
https://www.biospectrumasia.com/news/34/14965/pfizer-unveils-positive-results-for-vizimpro-as-first-line-monotherapy-in-nsclc-patients.html
https://www.fiercepharma.com/pharma/nice-shuts-down-az-s-tagrisso-and-backs-pfizer-rival-vizimpro-instead?utm_source=internal&utm_medium=rss
http://www.pharmatimes.com/news/nice_ok_for_life-extending_vizimpro_in_lung_cancer_1293312
https://www.fiercepharma.com/pharma/pfizer-never-say-never-m-a-buys-oncology-innovator-array-for-11-4b
https://www.in-pharmatechnologist.com/Article/2019/04/11/EU-marketing-authorization-given-to-Pfizer-for-Vizimpro
https://press.pfizer.com/press-release/vizimpro-dacomitinib-receives-marketing-authorization-european-union-eu-first-line-tre
https://www.raps.org/news-and-articles/news-articles/2019/2/emas-chmp-recommends-six-new-medicines-releases?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%201%20February
https://www.raps.org/news-and-articles/news-articles/2018/12/fda-drafts-guidance-on-oncology-companion-diagnost?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%207%20December
https://www.reuters.com/article/us-pfizer-fda/pfizers-lung-cancer-drug-gets-fda-approval-idUSKCN1M72UW
https://www.forbes.com/sites/greatspeculations/2018/07/02/how-sensitive-is-pfizer-to-rd-expense-changes/#1a6f7f16230f
https://www.fiercebiotech.com/biotech/asco-pfizer-s-dacomitinib-bests-iressa-nsclc-overall-survival-showdown
https://www.businesswire.com/news/home/20180604006445/en/Dacomitinib-Shows-Seven-Month-Improvement-Survival-Compared-Established
http://www.pharmatimes.com/news/pfizer_files_lung_cancer_drug_in_the_eu,_us_1230459
Market Place
Share 
